What Is The Best Price To Earnings Ratio At Which To Buy A Share Or Stock?

By Sunil Fernandes
Subscribe to GoodReturns
For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts

    One of the basic fundamental ratios to analyze whether a share is worth buying and is undervalued is to look at the price to earnings ratio or p/e ratio.

    Price to earnings ratio is arrived at by dividing the EPS by the current market price. Read how to calculate and what is p/e ratio

    Why P/E ratio is not the best way to analyse a share?

    What Is The Best Price To Earnings Ratio At Which To Buy A Share Or Stock?
    At what price to earnings ratio to buy a share is not the best way to do a fundamental analysis of a stock. Let's give an example. Currently, pharma stocks trade at a price to earnings multiple of 45-55 times. You can hardly find a good quality pharma stock trading below this p/e multiple.

    On the other hand PSU banking shares are trading at a p/e of just 6-7 times. Now, if they are trading at such low p/e does it make them attractive buys because they are cheaper.

    The answer is probably not. The reason for them are plenty and let's examine them.
    Markets look at growth prospects

    The future growth potential is of utmost importance to markets. So, if pharma companies are growing at 20-40 per cent, the markets are prepared to pay a hefty premium for them, which is why some pharma shares like Dr Reddys, Glenmark Pharma and Sun Pharma trade at ridiculously high p/e levels.

    On the other hand individuals are not ready to buy government banking shares despite a low p/e multiple because of problems with growth, asset quality etc.

    Management

    Individuals also look at the quality of management and may accord a premium in terms of price to earnings multiples for quality management and companies that are professionally run.

    Innovation

    Investors would look at future growth through innovation and ingenuity, which is why pharma companies have an edge.

    Compare peer within the industry

    Some investors tend to compare price to earnings ration of peers within the industry. But, here again one must keep in mind that a company that has expansion plans, a quality management, brand equity and solid track record will command a higher price to earnings ratio.

    Therefore, one cannot look at this ratio in isolation.

    GoodReturns.in

    Read more about: pe eps sun pharma
    Story first published: Monday, August 17, 2015, 10:17 [IST]
    Company Search
    Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'

    Find IFSC

    We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more